SPAGO NANOMEDICAL AB revenue for the last year amounted to 6.00 M SEK, the most of which — 1.20 M SEK — came from its highest performing source at the moment, Nanomedicine, the year earlier bringing 1.05 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought SPAGO NANOMEDICAL AB 1.20 M SEK, and the year before that — 1.05 M SEK.